Vimarsana
Biggest News Aggregation in the World

Page 2 - Advanced Hematologic News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Advanced Hematologic. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Advanced Hematologic Today - Breaking & Trending Today

Precigen, Inc. Provides Pipeline and Corporate Updates at the 41st Annual J.P. Morgan Healthcare Conference - Vimarsana News

Precigen, Inc. Provides Pipeline and Corporate Updates at the 41st Annual J.P. Morgan Healthcare Conference

Published: January 12, 2023

Precigen, Inc. presented pipeline and corporate updates at the 41st Annual J.P. Morgan Healthcare Conference. PRGN-2012 AdenoVerse™ Immunotherapy in RRP. Overview: PRGN-2012 is an investigational... | January 12, 2023

Source: marketscreener.com
Related Topics:
United StatesMayo Clinic In RochesterHelen SabzevariClintt AllenAmerican Society Of HematologyCancer ResearchNational Cancer InstituteDrug AdministrationSurgical Oncology ProgramProgram StatusPrecigen IncOrphan Drug DesignationSenior InvestigatorCancers OverviewAcute Myeloid LeukemiaFast Track DesignationAmerican SocietyAnnual MeetingMayo ClinicOvarian Cancer OverviewDose LevelDose Expansion StudyAdvanced HematologicSolid Tumor MalignanciesNc Stock Exchange
Precigen Reports Third Quarter 2022 Financial Results and Progress of Clinical Programs - Vimarsana News

Precigen Reports Third Quarter 2022 Financial Results and Progress of Clinical Programs

Published: November 9, 2022

– Company will host virtual R&D event in early January 2023, timed to coincide with the 41st Annual JP Morgan Healthcare Conference, to showcase complete...

Source: prnewswire.com
Related Topics:
United StatesMayo Clinic In RochesterHarry Thomasian JrStevenm HarasymHelen SabzevariClintt AllenNational Cancer InstituteSurgical Oncology ProgramDrug AdministrationExchange CommissionCancer ResearchAmerican Society Of HematologyKey ProgramPrecigen IncHealthcare ConferenceAmerican SocietyAnnual MeetingTrans OvaSenior InvestigatorSafety StudyPositive Acute Myeloid LeukemiaHigher Risk Myelodysplastic SyndromesMayo ClinicDose LevelDose Expansion Study